津投城開(600322.SH):終止轉讓控股子公司股權
格隆匯12月26日丨津投城開(600322.SH)公佈,在交易推進過程中,交易雙方就本次交易方案事宜進行進一步溝通,但最終未就相關事宜達成一致意見,公司對上述擬轉讓股權進行了重新籌劃。經交易雙方友好協商、認真研究和充分論證,從維護公司及股東利益角度出發,決定終止本次交易。公司於2024年12月26日召開十一屆二十三次臨時董事會會議,審議通過了《關於終止轉讓控股子公司天津市天薊房地產開發有限責任公司60%股權的議案》,同意終止本次交易。
截至本公吿披露日,公司擬轉讓天薊公司股權事項尚未正式實施,本次交易的終止,不存在任何未決爭議及違約事項,本次終止轉讓天薊公司股權事項不存在協議糾紛和違約責任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.